Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Silverback Therapeutics Q2 EPS $(0.70) Up From $(9.65) YoY

Silverback Therapeutics (NASDAQ:SBTX) reported quarterly losses of $(0.70) per share. This is a 92.75 percent increase over losses of $(9.65) per share from the same period last year.

Silverback Therapeutics (NASDAQ:SBTX) reported quarterly losses of $(0.70) per share. This is a 92.75 percent increase over losses of $(9.65) per share from the same period last year.

Total
0
Shares